Oragenics Inc (OGEN): Dilution is over for now.

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	190
Posts	14283
Boards Moderated	0
Alias Born	04/18/2017

Alexxdj1

Re: Vincent1974 post# 326

Monday, 10/08/2018 9:24:44 PM

Monday, October 08, 2018 9:24:44 PM

Dilution is over for now.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent OGEN News

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients • GlobeNewswire Inc. • 08/21/2024 12:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 12:30:09 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:45:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:30:15 PM
Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards • GlobeNewswire Inc. • 08/16/2024 08:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:30:38 PM
Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range • GlobeNewswire Inc. • 08/14/2024 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:30:14 PM
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study • GlobeNewswire Inc. • 08/12/2024 12:30:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:30:43 PM
Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing • GlobeNewswire Inc. • 08/08/2024 12:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:30:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 08:05:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 12:00:30 PM
Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients • GlobeNewswire Inc. • 07/10/2024 12:00:00 PM
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients • GlobeNewswire Inc. • 06/27/2024 12:30:40 PM
Oragenics, Inc. Announces Closing of Public Offering • GlobeNewswire Inc. • 06/26/2024 08:47:15 PM
Oragenics, Inc. Announces Pricing of Public Offering • GlobeNewswire Inc. • 06/25/2024 12:30:00 PM
Oragenics, Inc. Announces Proposed Public Offering • GlobeNewswire Inc. • 06/24/2024 10:43:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:00:24 PM
Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance • GlobeNewswire Inc. • 06/20/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 01:27:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 12:00:17 PM
Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer • GlobeNewswire Inc. • 05/22/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 12:00:41 PM

More OGEN News

InvestorsHub NewsWire

FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM

PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM

Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM

North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM

All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM

Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover